Blueprint Medicines Corporation (BPMC)
USD 80.71
(-7.35%)
USD 80.71
(-7.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 702.83 Million USD | 472.61% |
| 2022 | 122.74 Million USD | 224.56% |
| 2021 | -98.54 Million USD | 83.44% |
| 2020 | -595.03 Million USD | -3207.75% |
| 2019 | -17.98 Million USD | 66.34% |
| 2018 | -53.44 Million USD | 91.87% |
| 2017 | -657.02 Million USD | -148.08% |
| 2016 | -264.84 Million USD | -66.82% |
| 2015 | -158.75 Million USD | -315.62% |
| 2014 | -38.19 Million USD | -4460.5% |
| 2013 | 876 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 484.6 Million USD | -31.05% |
| 2024 Q3 | 297.21 Million USD | -44.26% |
| 2024 Q2 | 685.57 Million USD | 41.47% |
| 2023 Q4 | 702.83 Million USD | 905.46% |
| 2023 FY | 702.83 Million USD | 472.61% |
| 2023 Q1 | -51.51 Million USD | -141.97% |
| 2023 Q2 | 40.67 Million USD | 178.95% |
| 2023 Q3 | 69.9 Million USD | 71.87% |
| 2022 Q2 | -65.8 Million USD | -190.98% |
| 2022 Q1 | 72.32 Million USD | 173.4% |
| 2022 Q4 | 122.74 Million USD | 358.57% |
| 2022 Q3 | -47.46 Million USD | 27.86% |
| 2022 FY | 122.74 Million USD | 224.56% |
| 2021 Q1 | -610.29 Million USD | -2.57% |
| 2021 FY | -98.54 Million USD | 83.44% |
| 2021 Q4 | -98.54 Million USD | 79.02% |
| 2021 Q3 | -469.72 Million USD | -4.71% |
| 2021 Q2 | -448.58 Million USD | 26.5% |
| 2020 Q1 | -280.33 Million USD | -1458.35% |
| 2020 FY | -595.03 Million USD | -3207.75% |
| 2020 Q3 | -473.81 Million USD | -142.32% |
| 2020 Q2 | -195.53 Million USD | 30.25% |
| 2020 Q4 | -595.03 Million USD | -25.58% |
| 2019 Q3 | 8.27 Million USD | -50.11% |
| 2019 FY | -17.98 Million USD | 66.34% |
| 2019 Q4 | -17.98 Million USD | -317.49% |
| 2019 Q2 | 16.57 Million USD | -17.97% |
| 2019 Q1 | 20.2 Million USD | 137.81% |
| 2018 Q4 | -53.44 Million USD | 15.59% |
| 2018 FY | -53.44 Million USD | 91.87% |
| 2018 Q1 | -117.87 Million USD | 82.06% |
| 2018 Q2 | -101.58 Million USD | 13.82% |
| 2018 Q3 | -63.31 Million USD | 37.67% |
| 2017 Q4 | -657.02 Million USD | -1349.3% |
| 2017 Q3 | -45.33 Million USD | 46.0% |
| 2017 FY | -657.02 Million USD | -148.08% |
| 2017 Q1 | -49.88 Million USD | 81.17% |
| 2017 Q2 | -83.95 Million USD | -68.3% |
| 2016 FY | -264.84 Million USD | -66.82% |
| 2016 Q3 | -66 Million USD | 34.01% |
| 2016 Q4 | -264.84 Million USD | -301.28% |
| 2016 Q2 | -100.02 Million USD | 10.67% |
| 2016 Q1 | -111.96 Million USD | 29.47% |
| 2015 Q4 | -158.75 Million USD | 5.4% |
| 2015 FY | -158.75 Million USD | -315.62% |
| 2015 Q2 | -181.08 Million USD | -334.83% |
| 2015 Q1 | -41.64 Million USD | -9.03% |
| 2015 Q3 | -167.81 Million USD | 7.33% |
| 2014 FY | -38.19 Million USD | -4460.5% |
| 2014 Q1 | 1.98 Million USD | 0.0% |
| 2014 Q4 | -38.19 Million USD | 0.0% |
| 2013 FY | 876 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 1356.41% |
| Alkermes plc | -166.73 Million USD | 521.519% |
| Agenus Inc. | 274.13 Million USD | -156.382% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 62.414% |
| Aptorum Group Limited | 1.35 Million USD | -51691.612% |
| Ardelyx, Inc. | 34.51 Million USD | -1936.497% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -16321.402% |
| Bicycle Therapeutics plc | -481.46 Million USD | 245.978% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -1843.522% |
| ChromaDex Corporation | -24.04 Million USD | 3022.638% |
| Chimerix, Inc. | -25.51 Million USD | 2854.383% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -9986.515% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 3068.434% |
| CRISPR Therapeutics AG | -150.84 Million USD | 565.933% |
| Precision BioSciences, Inc. | -85.41 Million USD | 922.897% |
| Dyadic International, Inc. | -6.37 Million USD | 11119.522% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 4511.197% |
| Fortress Biotech, Inc. | 7.66 Million USD | -9069.419% |
| Lantern Pharma Inc. | -21.7 Million USD | 3338.386% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 735.838% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 8326.87% |
| Incyte Corporation | -3.17 Billion USD | 122.136% |
| IO Biotech, Inc. | -140.69 Million USD | 599.532% |
| Jaguar Health, Inc. | 29.39 Million USD | -2291.331% |
| Novavax, Inc. | -298.29 Million USD | 335.619% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -13069.121% |
| Opthea Limited | 28.15 Million USD | -2396.093% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 4286.289% |
| ContextLogic Inc. | -232 Million USD | 402.947% |
| MiMedx Group, Inc. | -33.9 Million USD | 2173.201% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -6793.928% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 30433.527% |
| NextCure, Inc. | -6.47 Million USD | 10951.258% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 1491.727% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 11117.965% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -5678.349% |
| Vaxcyte, Inc. | -368.22 Million USD | 290.87% |
| PDS Biotechnology Corporation | -32.7 Million USD | 2248.761% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -3967.809% |
| Pharming Group N.V. | 109.8 Million USD | -540.082% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 4140.216% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 501.093% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3895.04% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3895.04% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 9999.099% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 12093.788% |
| Acelyrin, Inc. | -216.9 Million USD | 424.032% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 12627.675% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 40867.749% |
| Summit Therapeutics Inc. | 34.67 Million USD | -1926.983% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 10431.266% |
| Senti Biosciences, Inc. | 1.74 Million USD | -40292.874% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 480.72% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 1007.459% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 11694.127% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -704363.31% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -111816.561% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 700.478% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 517.775% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -533.928% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 9352.712% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 644.353% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -10094.01% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 389.993% |
| Immix Biopharma, Inc. | -17.5 Million USD | 4113.96% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 321.923% |
| MEI Pharma, Inc. | -3.7 Million USD | 19069.933% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -5517.744% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -334.541% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -2428.824% |
| Fortress Biotech, Inc. | 7.66 Million USD | -9069.419% |
| Precigen, Inc. | -481 Thousand USD | 146219.751% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -4891.378% |
| AlloVir, Inc. | -62.69 Million USD | 1221.094% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 1363.775% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -1039.746% |
| ImmuCell Corporation | 10.99 Million USD | -6294.905% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 555.955% |
| Onconetix, Inc. | 5.33 Million USD | -13082.862% |
| PureTech Health plc | -167.19 Million USD | 520.364% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 2407.406% |
| Elevation Oncology, Inc. | -19.11 Million USD | 3776.305% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 14417.295% |
| Seer, Inc. | -4.24 Million USD | 16676.321% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 3023.976% |
| Innoviva, Inc. | 255.56 Million USD | -175.015% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 1358.12% |
| ESSA Pharma Inc. | -33.62 Million USD | 2190.431% |
| GlycoMimetics, Inc. | -40.98 Million USD | 1814.885% |
| GT Biopharma, Inc. | -1.02 Million USD | 68938.002% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 1136.891% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -1047.356% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 624.195% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 5172.431% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 2534.317% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 933059.885% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 2377.351% |
| Aptose Biosciences Inc. | -8.19 Million USD | 8676.55% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 22561.871% |
| Soligenix, Inc. | -4.95 Million USD | 14294.128% |
| Century Therapeutics, Inc. | 847 Thousand USD | -82879.457% |
| Kura Oncology, Inc. | -20.11 Million USD | 3593.568% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 1817.334% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 8469.088% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -38481.431% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 22084.235% |
| Autolus Therapeutics plc | -186.59 Million USD | 476.656% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 1525.515% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 354.841% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -1950.998% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -327.599% |
| GRI Bio, Inc. | -1.79 Million USD | 39277.035% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 7924.028% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 2213.348% |
| IGM Biosciences, Inc. | -72.6 Million USD | 1068.014% |
| INmune Bio, Inc. | -25.41 Million USD | 2865.873% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -365.605% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1487.386% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 4425.312% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 24462.358% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -1748.839% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 1806.534% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -2104.284% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -85.96% |
| Verastem, Inc. | -37.27 Million USD | 1985.391% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 7846.457% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 1455.204% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 4743.779% |
| Histogen Inc. | -7.48 Million USD | 9487.418% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 3352.843% |
| Surrozen, Inc. | -32.66 Million USD | 2251.714% |
| Organovo Holdings, Inc. | -1.5 Million USD | 46738.089% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 16820.305% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -3606.9% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -26766.82% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -16811.357% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 8485.914% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 1717.872% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 4921.587% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 321.863% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 97437.617% |
| Apollomics, Inc. | -27.39 Million USD | 2665.563% |
| Amarin Corporation plc | -191.04 Million USD | 467.9% |
| Mesoblast Limited | 55.96 Million USD | -1155.894% |
| Turnstone Biologics Corp. | -14.58 Million USD | 4919.227% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 2878.887% |
| Synaptogenix, Inc. | -28.66 Million USD | 2552.196% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 75189.316% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -1342.247% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 81627.081% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 9772.836% |
| Exelixis, Inc. | -73.05 Million USD | 1062.13% |
| Better Therapeutics, Inc. | -860 Thousand USD | 81825.116% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 3026.898% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 391.185% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -95385.459% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 9549.089% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -55947.528% |
| Gritstone bio, Inc. | 39.49 Million USD | -1679.782% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 935.705% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 26802.075% |
| Avid Bioservices, Inc. | 169.72 Million USD | -314.095% |
| Insmed Incorporated | 721.62 Million USD | 2.603% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 7788.4% |
| MediWound Ltd. | -5.32 Million USD | 13306.238% |
| OmniAb, Inc. | 9.2 Million USD | -7537.031% |
| Alector, Inc. | -35.63 Million USD | 2072.209% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -717.527% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 14362.094% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -5208.83% |
| Zai Lab Limited | -775 Million USD | 190.689% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -106.38% |
| Aura Biosciences, Inc. | -21.52 Million USD | 3365.208% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 952.129% |
| Immunic, Inc. | -45.34 Million USD | 1650.146% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 463.759% |
| Veracyte, Inc. | -203.82 Million USD | 444.825% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -10.112% |
| FibroGen, Inc. | 56.76 Million USD | -1138.107% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -7792.6% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 24960.828% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 34047.723% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 84.689% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 21136.696% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 523.487% |
| TG Therapeutics, Inc. | 17.86 Million USD | -3834.811% |
| Galecto, Inc. | -21.21 Million USD | 3412.764% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 3054.955% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 55.216% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 2972.001% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 6207.9% |
| XBiotech Inc. | -200.02 Million USD | 451.378% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 935.705% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -15421.996% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 2093.126% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 1010.197% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -12249.956% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 512.426% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 860.859% |
| Vaxxinity, Inc. | 10.13 Million USD | -6836.794% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 4.54% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 6627.352% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 1165.613% |
| NexImmune, Inc. | -3.13 Million USD | 22528.72% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 20456.286% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 4751.016% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 2693.491% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 7930.123% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 564287.036% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 1832.318% |
| Ainos, Inc. | 4.07 Million USD | -17135.125% |
| Pluri Inc. | 22.82 Million USD | -2978.698% |
| Prothena Corporation plc | -608.34 Million USD | 215.532% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 691.832% |
| Celularity Inc. | 65.19 Million USD | -978.135% |
| Rallybio Corporation | -24.1 Million USD | 3016.09% |
| Cue Biopharma, Inc. | -33.81 Million USD | 2178.228% |
| MeiraGTx Holdings plc | -40.3 Million USD | 1843.923% |
| Omeros Corporation | 331.17 Million USD | -112.224% |
| Humacyte, Inc. | -22.48 Million USD | 3225.66% |
| Immunocore Holdings plc | -358.59 Million USD | 295.998% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 2959.963% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 2374.477% |
| CalciMedica, Inc. | -5.53 Million USD | 12809.512% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 473.412% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 6981.104% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 1855.466% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 2213.602% |
| Pulmatrix, Inc. | -10.41 Million USD | 6847.01% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 11859.01% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 1942.683% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 730.901% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 1272.487% |
| Cytokinetics, Incorporated | 642.37 Million USD | -9.413% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 12169.998% |
| Nutriband Inc. | -251.65 Thousand USD | 279383.31% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 2159.955% |
| Vor Biopharma Inc. | 4.3 Million USD | -16245.023% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 111.644% |
| Evogene Ltd. | -19.63 Million USD | 3679.688% |
| ProKidney Corp. | -56.23 Million USD | 1349.797% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 1544.025% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 7708.767% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 48.469% |
| CorMedix Inc. | -43.05 Million USD | 1732.509% |
| BioLineRx Ltd. | 7.33 Million USD | -9480.643% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 2659.024% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -1423.037% |
| Atai Life Sciences N.V. | -28.55 Million USD | 2561.083% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -31409.835% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 3180.452% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -3862.988% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 1036.191% |
| MediciNova, Inc. | -50.78 Million USD | 1483.985% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 991.867% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 3124509.869% |
| GeoVax Labs, Inc. | -6.45 Million USD | 10992.31% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 451.733% |
| Biomea Fusion, Inc. | -166.57 Million USD | 521.946% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 492.701% |
| Mereo BioPharma Group plc | -51.46 Million USD | 1465.552% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 841.044% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 339.256% |
| Absci Corporation | -72.59 Million USD | 1068.12% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -15292.816% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 399.797% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 846.023% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 834.447% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 1898.777% |
| Allakos Inc. | -24.97 Million USD | 2914.158% |
| Imunon, Inc. | -4.21 Million USD | 16779.181% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 4867.576% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 619.081% |
| BioAtla, Inc. | -109.01 Million USD | 744.739% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -95385.459% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 74949.414% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -5773.609% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 3414.795% |
| XOMA Corporation | -29 Million USD | 2523.572% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 4344.179% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 7895.43% |
| aTyr Pharma, Inc. | -7.44 Million USD | 9535.307% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 663.911% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 437.636% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 959.433% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 857.668% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 81902.734% |
| Akari Therapeutics, Plc | -3.84 Million USD | 18379.22% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -43207.68% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 49.102% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 59254.557% |
| UroGen Pharma Ltd. | 4.39 Million USD | -15906.286% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -519.342% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -976576.579% |
| Orgenesis Inc. | 21.78 Million USD | -3126.386% |
| Entera Bio Ltd. | -10.62 Million USD | 6712.438% |
| GH Research PLC | -78.07 Million USD | 1000.183% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 3253.428% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 2736.393% |
| Xencor, Inc. | 29.64 Million USD | -2270.922% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 35780.359% |
| Replimune Group, Inc. | 1.41 Million USD | -49675.921% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 287079.601% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 655.966% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 59254.557% |
| Portage Biotech Inc. | -4.98 Million USD | 14210.339% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 3124509.869% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 1162.938% |
| OncoCyte Corporation | -6.56 Million USD | 10809.066% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -78218.01% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 15527.811% |
| Purple Biotech Ltd. | -14.13 Million USD | 5071.255% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 3058.562% |
| scPharmaceuticals Inc. | -6.54 Million USD | 10838.518% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 4310.574% |
| HilleVax, Inc. | -165.48 Million USD | 524.713% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 27792.514% |
| Tharimmune, Inc. | -10.93 Million USD | 6527.191% |
| Genprex, Inc. | -6.73 Million USD | 10531.503% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 290.57% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 894.524% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 50266.738% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 21289.251% |
| OKYO Pharma Limited | -826.84 Thousand USD | 85101.838% |
| Savara Inc. | 153 Thousand USD | -459269.935% |
| Curis, Inc. | -23.88 Million USD | 3042.337% |
| Daré Bioscience, Inc. | -5.15 Million USD | 13726.369% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 90670.249% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 11421.456% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -59211.055% |
| BeiGene, Ltd. | -2.25 Billion USD | 131.194% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -5596.284% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 215.559% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 478.712% |
| Erasca, Inc. | -37.21 Million USD | 1988.532% |
| bluebird bio, Inc. | 108.57 Million USD | -547.352% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 54672.546% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -85.568% |
| DBV Technologies S.A. | -126.98 Million USD | 653.475% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 54672.546% |
| Moderna, Inc. | -2.9 Billion USD | 124.177% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 6889.374% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 6567.022% |
| Molecular Templates, Inc. | 707 Thousand USD | -99311.033% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 2340.4% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -102.775% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 956.469% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 866.201% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 2277.851% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 2144.554% |
| MacroGenics, Inc. | -66.98 Million USD | 1149.244% |
| RenovoRx, Inc. | -1.17 Million USD | 60017.818% |
| Adicet Bio, Inc. | -138.78 Million USD | 606.413% |
| Prime Medicine, Inc. | -27.94 Million USD | 2615.429% |
| Aditxt, Inc. | 18.12 Million USD | -3778.596% |
| Adagene Inc. | -87.62 Million USD | 902.073% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 16973.08% |
| Quantum-Si incorporated | -118.55 Million USD | 692.825% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -1852.051% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 9503.51% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 1548.878% |
| SciSparc Ltd. | -2.06 Million USD | 34135.642% |
| Vericel Corporation | 1.27 Million USD | -54938.058% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 5961.02% |
| Minerva Neurosciences, Inc. | 41 Million USD | -1614.057% |
| Generation Bio Co. | 31.44 Million USD | -2134.915% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 500.787% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 2372.858% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -502.811% |
| Invivyd, Inc. | -198.47 Million USD | 454.116% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 878.593% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 29413.068% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 1092.846% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 10397.963% |
| 2seventy bio, Inc. | 181.71 Million USD | -286.779% |
| ADMA Biologics, Inc. | 90.06 Million USD | -680.357% |
| Clene Inc. | 3.34 Million USD | -20942.994% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 7838.181% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 3367.333% |
| GeoVax Labs, Inc. | -6.45 Million USD | 10992.31% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 304.239% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 2803.248% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -295.594% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 17277.673% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -13951.1% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 13592.724% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 639.382% |
| Evaxion Biotech A/S | 5.28 Million USD | -13194.056% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 724.366% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 635.4% |
| Trevena, Inc. | 2.25 Million USD | -31026.484% |
| Surrozen, Inc. | -32.66 Million USD | 2251.714% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 1464.465% |
| Cingulate Inc. | 3.08 Million USD | -22699.49% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 24030.405% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -9679.268% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 7664.512% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 986.043% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 634.671% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 765.93% |
| Clearmind Medicine Inc. | -3.94 Million USD | 17926.546% |
| Kronos Bio, Inc. | -36.05 Million USD | 2049.398% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -7369.827% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -48101.288% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 1395.407% |
| Statera Biopharma, Inc. | 14.41 Million USD | -4775.251% |
| ImmunityBio, Inc. | 618.22 Million USD | -13.686% |
| Korro Bio, Inc. | -132.94 Million USD | 628.675% |
| Kineta, Inc. | -4.54 Million USD | 15577.56% |
| BioVie Inc. | -17.73 Million USD | 4063.58% |
| Codexis, Inc. | -43.27 Million USD | 1724.266% |
| Celularity Inc. | 65.19 Million USD | -978.135% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 22278.479% |
| Celcuity Inc. | 6.78 Million USD | -10260.95% |
| Virax Biolabs Group Limited | -3.36 Million USD | 20987.004% |
| Cibus, Inc. | -8.07 Million USD | 8800.619% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 16719.437% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -15279.344% |
| IN8bio, Inc. | -16.38 Million USD | 4388.462% |
| Kodiak Sciences Inc. | -103.87 Million USD | 776.617% |
| Annexon, Inc. | -193.75 Million USD | 462.745% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -1952222.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 4116.435% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 20106.718% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 33.335% |
| Eyenovia, Inc. | 1.25 Million USD | -55738.157% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -2512.288% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 21772.402% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 2213.983% |
| Arcellx, Inc. | -296.95 Million USD | 336.679% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 3703.179% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 1293.777% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 3490.92% |
| Moolec Science SA | 117.61 Thousand USD | -597468.358% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 1930.35% |
| Geron Corporation | 14.76 Million USD | -4661.439% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 1953.568% |
| Royalty Pharma plc | 5.65 Billion USD | 87.579% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 596.981% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 10155.707% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 13205.621% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 599.418% |
| Humacyte, Inc. | -22.48 Million USD | 3225.66% |
| Structure Therapeutics Inc. | -124.33 Million USD | 665.258% |
| 89bio, Inc. | -289.05 Million USD | 343.151% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 2884.391% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 39518.732% |
| Genelux Corporation | -6.89 Million USD | 10287.505% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 2362.906% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -740.723% |
| Notable Labs, Ltd. | -9.77 Million USD | 7289.403% |
| Liquidia Corporation | -80.17 Million USD | 976.616% |
| Mustang Bio, Inc. | -3.73 Million USD | 18912.527% |
| Immunovant, Inc. | -635.22 Million USD | 210.643% |
| Quantum-Si incorporated | -118.55 Million USD | 692.825% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 4101.571% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 17064.422% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -8655.899% |
| Acasti Pharma Inc. | -23 Million USD | 3155.145% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 20972.83% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 4425.312% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 610.263% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 22653.092% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 3261.371% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 3884.996% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 515.196% |
| PepGen Inc. | -60.67 Million USD | 1258.457% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 3159.001% |
| United Therapeutics Corporation | -507.7 Million USD | 238.435% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 3774.767% |
| Solid Biosciences Inc. | -47.75 Million USD | 1571.908% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 81627.081% |
| Immuneering Corporation | -54.94 Million USD | 1379.213% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 16820.305% |
| Silo Pharma, Inc. | -3.52 Million USD | 20042.525% |
| Belite Bio, Inc | -87.27 Million USD | 905.349% |
| XOMA Corporation | -29 Million USD | 2523.572% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 1094.153% |
| Bionomics Limited | 227 Million USD | -209.606% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 704.424% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 27847.177% |
| uniQure N.V. | -102.95 Million USD | 782.69% |
| Cassava Sciences, Inc. | -121.13 Million USD | 680.204% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 16973.08% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -1616.285% |
| Forte Biosciences, Inc. | -11.96 Million USD | 5976.064% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 22814.627% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -662952.83% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 21772.402% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -7792.6% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 9577.292% |
| Altimmune, Inc. | -134.48 Million USD | 622.605% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -254.851% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 27847.177% |
| Compugen Ltd. | -12.9 Million USD | 5546.652% |
| Peak Bio, Inc. | 10.34 Million USD | -6697.15% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 248451.943% |
| Benitec Biopharma Inc. | -50.58 Million USD | 1489.498% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 773.615% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -3477.684% |
| Zura Bio Limited | -99.8 Million USD | 804.202% |
| PolyPid Ltd. | 6.17 Million USD | -11291.183% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -848.241% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -3477.684% |
| Instil Bio, Inc. | 75.35 Million USD | -832.663% |
| argenx SE | -2.02 Billion USD | 134.642% |
| Immunome, Inc. | -97.02 Million USD | 824.357% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 3224.41% |
| Verona Pharma plc | -220.44 Million USD | 418.829% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 1079.658% |
| Shattuck Labs, Inc. | -121.42 Million USD | 678.828% |
| CervoMed Inc. | -7.79 Million USD | 9118.99% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 478.889% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 16172.17% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 633.502% |
| Moolec Science SA | 117.61 Thousand USD | -597468.358% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 30818.665% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -4320.803% |
| AnaptysBio, Inc. | -18.15 Million USD | 3972.161% |
| Design Therapeutics, Inc. | -18.15 Million USD | 3972.375% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 1098.616% |
| NeurAxis, Inc. | 145.7 Thousand USD | -482285.724% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -6157.443% |
| Lumos Pharma, Inc. | -28.49 Million USD | 2566.697% |
| Achilles Therapeutics plc | -126.92 Million USD | 653.746% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 1079.658% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 107283.749% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 3483.277% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -48101.288% |
| Nutriband Inc. | -251.65 Thousand USD | 279383.31% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 5436.239% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 9546.72% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -106.597% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -2861.18% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 257.068% |
| Palisade Bio, Inc. | -12.06 Million USD | 5926.378% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 600.913% |
| Beam Therapeutics Inc. | -262.72 Million USD | 367.521% |
| Neurogene Inc. | -131.95 Million USD | 632.633% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -3121.654% |
| AEON Biopharma, Inc. | -4.88 Million USD | 14502.377% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 286.334% |
| Sesen Bio, Inc. | -112.55 Million USD | 724.449% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 803.821% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 30036.029% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 1900.943% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 943.923% |
| Athira Pharma, Inc. | -88.99 Million USD | 889.712% |
| Vaccinex, Inc. | -1.28 Million USD | 54668.012% |
| HCW Biologics Inc. | 2.85 Million USD | -24503.28% |
| XOMA Corporation | -29 Million USD | 2523.572% |
| Nektar Therapeutics | 210.24 Million USD | -234.302% |
| Arvinas, Inc. | -313.8 Million USD | 323.976% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -43207.68% |
| Merus N.V. | -192.88 Million USD | 464.383% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -1071.686% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 10230.239% |
| Rezolute, Inc. | -68.16 Million USD | 1131.035% |
| Clene Inc. | 3.34 Million USD | -20942.994% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 5429.764% |
| BeyondSpring Inc. | -13.75 Million USD | 5209.676% |
| Synlogic, Inc. | -6.68 Million USD | 10613.628% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -61878.483% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 8412.667% |
| Peak Bio, Inc. | 10.34 Million USD | -6697.15% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 952.749% |
| Krystal Biotech, Inc. | -350.23 Million USD | 300.676% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -466.232% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 515.889% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 22361.766% |
| MannKind Corporation | 143.89 Million USD | -388.423% |
| Ikena Oncology, Inc. | -109.15 Million USD | 743.882% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 9383.265% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 2223.372% |
| Gossamer Bio, Inc. | 180.35 Million USD | -289.696% |
| CohBar, Inc. | -5.93 Million USD | 11950.748% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 2462.633% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -15292.816% |
| Legend Biotech Corporation | -949.39 Million USD | 174.03% |
| Mural Oncology plc | -255.84 Million USD | 374.714% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -2081.704% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 15020.174% |
| Disc Medicine, Inc. | -358.28 Million USD | 296.169% |
| Champions Oncology, Inc. | 4.81 Million USD | -14505.902% |
| REGENXBIO Inc. | 54.76 Million USD | -1183.297% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 261467.685% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 565.38% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 7898.885% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 971.108% |
| Vaxart, Inc. | -8.24 Million USD | 8628.528% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 1500.631% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 652.693% |
| Cellectis S.A. | -43.85 Million USD | 1702.636% |
| Longeveron Inc. | -2.9 Million USD | 24269.051% |
| Repare Therapeutics Inc. | -107.85 Million USD | 751.631% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 27.421% |
| Inozyme Pharma, Inc. | 12 Million USD | -5755.015% |
| Revolution Medicines, Inc. | -608.2 Million USD | 215.559% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 57241.138% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 365.104% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 568.333% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 4591.826% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 95077.838% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 107.349% |
| Denali Therapeutics Inc. | -74.86 Million USD | 1038.805% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 5961.02% |
| Veru Inc. | 4.77 Million USD | -14603.777% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 6349.653% |
| Cingulate Inc. | 3.08 Million USD | -22699.49% |
| Passage Bio, Inc. | 4.58 Million USD | -15229.029% |
| Context Therapeutics Inc. | -14.44 Million USD | 4963.975% |
| Exicure, Inc. | 5.84 Million USD | -11916.345% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 405.082% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 1876.184% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -4379.23% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 1294.873% |
| Nuvalent, Inc. | -335.38 Million USD | 309.56% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -40424.672% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 1043.632% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 8005.917% |
| OmniAb, Inc. | 9.2 Million USD | -7537.031% |
| Anew Medical, Inc. | 1.43 Million USD | -48964.794% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -4190.358% |
| Lipocine Inc. | -4.75 Million USD | 14882.257% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 739.942% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -4514.51% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1487.386% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -2723.542% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 10557.313% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 1167.702% |
| Ocugen, Inc. | -32.52 Million USD | 2261.176% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 921.31% |
| Q32 Bio Inc. | -37.94 Million USD | 1952.103% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 112016.561% |
| Alumis Inc. Common Stock | -13.52 Million USD | 5295.033% |
| Equillium, Inc. | -22.39 Million USD | 3238.782% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 2848.889% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 2254.17% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 283598.78% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -424.34% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -21877.361% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -213891.554% |
| Dominari Holdings Inc. | 195 Thousand USD | -360328.718% |
| Edesa Biotech, Inc. | -5.26 Million USD | 13444.371% |
| vTv Therapeutics Inc. | -8.91 Million USD | 7981.978% |
| Bio-Techne Corporation | 267.74 Million USD | -162.5% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 4436.085% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 695.15% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 8464.108% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 5655.577% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 386.733% |
| Nkarta, Inc. | 57.29 Million USD | -1126.611% |
| BioCardia, Inc. | 212 Thousand USD | -331426.415% |
| Iterum Therapeutics plc | 13.43 Million USD | -5130.213% |